News : royalty

As a result of increased use of Enea’s software and after the quarterly reconciliation of the royalty-based volumes, Enea’s royalty revenue will be SEK 13 million higher than previously estimated. The amount will be recognized in December 2011.
"Most of Enea's revenues are recurring revenues with royalties as an important part.", said Anders Lidbeck, President and CEO of Enea. "Royalty is reported on a quarterly...

Moberg Derma AB today announces a license and co-promotion agreement with a leading Nordic OTC company for K101 - Moberg Derma’s novel treatment for nail fungus (onychomycosis). In the agreement, Moberg Derma will be responsible for supply of the product and promotion to prescribers, while its Nordic partner will be responsible for promotion to consumers. Financial terms are not disclosed but include up-front and...

Moberg Derma AB and MedPharm Ltd today announce a license and distribution agreement for the development, marketing and sales of new dermatology products that will combine Moberg Derma’s Kaprolac® platform with MedPharm’s MedSpray™ technology. According to the agreement, MedPharm will be eligible for royalty payments.
Moberg Derma obtains the exclusive rights to worldwide manufacturing, distribution and sales...